A. Varela‐Román

发表

A New Biomarker Tool for Risk Stratification in “de novo” Acute Heart Failure (OROME)

J. González-Juanatey, M. Couselo-Seijas, S. Eiras, 2021, Frontiers in Physiology.

Non classical Monocytes Levels, Increased by Subcutaneous Fat-Secretome, Are Associated with Less Rehospitalization after Heart Failure Admission

F. Casanueva, M. Carreira, Á. Fernández-Trasancos, 2017, Journal of Cardiovascular Translational Research.

Cardiac amyloidosis: Description of a series of 143 cases

M. Crespo-Leiro, E. Barge-Caballero, C. González-Juanatey, 2022, Medicina Clínica (English Edition).

Evidence for a role of advanced glycation end products in atrial fibrillation.

S. Raposeiras-Roubín, J. González-Juanatey, L. Grigorian-Shamagian, 2012, International journal of cardiology.

Relation of soluble receptor for advanced glycation end products to predict mortality in patients with chronic heart failure independently of Seattle Heart Failure Score.

S. Raposeiras-Roubín, J. González-Juanatey, L. Grigorian-Shamagian, 2011, The American journal of cardiology.

Soluble receptor of advanced glycation end products levels are related to ischaemic aetiology and extent of coronary disease in chronic heart failure patients, independent of advanced glycation end products levels

S. Raposeiras-Roubín, J. González-Juanatey, L. Grigorian-Shamagian, 2010, European journal of heart failure.

The different roles for the advanced glycation end products axis in heart failure and acute coronary syndrome settings.

J. González-Juanatey, R. Agra, J. García-Acuña, 2019, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Clinical profile and outcomes in octogenarians with atrial fibrillation: A community-based study in a specific European health care area.

J. González-Juanatey, C. Peña-Gil, J. García-Acuña, 2017, International journal of cardiology.

Inflammatory effects of in vivo glycated albumin from cardiovascular patients.

J. González-Juanatey, S. Bravo, A. Varela-Román, 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Adherence to the ESC Heart Failure Treatment Guidelines in Spain: ESC Heart Failure Long-term Registry.

A. Bayés‐Genís, M. Crespo-Leiro, J. M. García-Pinilla, 2015, Revista espanola de cardiologia.

Soluble angiotensin-converting enzyme levels in heart failure or acute coronary syndrome: revisiting its modulation and prognosis value

J. González-Juanatey, C. Almenglo, M. Couselo-Seijas, 2021, Journal of Molecular Medicine.

Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry

J. González-Juanatey, L. Valdés-Cuadrado, N. Bouzas-Cruz, 2020, Revista Española de Cardiología (English Edition).

Influence of diabetes on the survival of patients hospitalized with heart failure: A 12‐year study

J. González-Juanatey, E. Caballero, L. G. Shamagian, 2005, European journal of heart failure.

Morbidity and mortality among heart failure patients in Galicia, N.W. Spain: the GALICAP Study.

J. González-Juanatey, L. Grigorian-Shamagian, I. López-Rodríguez, 2009, International journal of cardiology.

M. Calaza, Á. Fernández-Trasancos, M. Gago-Domínguez, 2019, Cardiovascular Drugs and Therapy.

Heart failure in patients with preserved and deteriorated left ventricular ejection fraction

J. González-Juanatey, A. Varela-Román, L. Grigorian, 2005, Heart.

Beta-Blocker Exposure and Survival in Patients With Transthyretin Amyloid Cardiomyopathy.

M. Crespo-Leiro, E. Barge-Caballero, C. González-Juanatey, 2021, Mayo Clinic proceedings.

Clinical characteristics and prognosis of hospitalised inpatients with heart failure and preserved or reduced left ventricular ejection fraction

F. Gudé, J. González-Juanatey, A. Varela-Román, 2002, Heart.

Syncope in patients with transthyretin amyloid cardiomyopathy: clinical features and outcomes

M. Crespo-Leiro, A. Varela-Román, E. Barge-Caballero, 2022, Postgraduate medicine.

P911Tolerability and safety of sacubitril/valsartan in high-risk subgroups

J. González-Juanatey, I. Gómez-Otero, A. Blanco, 2018 .

Long-Term Weight Gain Associated With High Omentin Levels at Hospital Discharge Improves Prognosis of Patients Following Acute Heart Failure

J. González-Juanatey, S. Eiras, R. Agra-Bermejo, 2018, Journal of Cardiovascular Translational Research.

Nutrients restriction upregulates adiponectin in epicardial or subcutaneous adipose tissue: impact in de novo heart failure patients

Á. Fernández-Trasancos, Á. L. Fernández, J. González-Juanatey, 2018, International journal of medical sciences.

Hyperkalemia in heart failure patients in Spain and its impact on guidelines and recommendations: ESC-EORP-HFA Heart Failure Long-Term Registry.

L. Lund, A. Bayés‐Genís, A. Maggioni, 2020, Revista espanola de cardiologia.

[Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry].

J. González-Juanatey, L. Valdés-Cuadrado, N. Bouzas-Cruz, 2020, Revista espanola de cardiologia.

Noninferiority of heart failure nurse titration versus heart failure cardiologist titration. ETIFIC multicenter randomized trial.

J. M. García-Pinilla, E. Arana-Arri, J. González-Costello, 2020, Revista espanola de cardiologia.

Evolution and bad prognostic value of advanced glycation end products after acute heart failure: relation with body composition

F. Casanueva, M. Carreira, Á. Fernández-Trasancos, 2017, Cardiovascular Diabetology.

Orosomucoid as prognosis factor associated with inflammation in acute or nutritional status in chronic heart failure.

F. Casanueva, M. Carreira, Á. Fernández-Trasancos, 2017, International journal of cardiology.

[Galician study of heart failure in primary care (GALICAP Study)].

J. González-Juanatey, L. Grigorian-Shamagian, I. López-Rodríguez, 2007, Revista espanola de cardiologia.

Risk stratification for the development of heart failure after acute coronary syndrome at the time of hospital discharge: Predictive ability of GRACE risk score.

S. Raposeiras-Roubín, E. Abu-Assi, J. González-Juanatey, 2015, Journal of cardiology.

Impacto de los inhibidores de la enzima de conversión de la angiotensina y los antagonistas del receptor de la angiotensina II en la COVID-19 en una población occidental. Registro CARDIOVID

J. González-Juanatey, L. Valdés-Cuadrado, J. R. González-Juanatey, 2020, Revista Española de Cardiología.

Morbidity and mortality among heart failure patients in Galicia, N.W. Spain: the GALICAP Study.

J. González-Juanatey, L. Grigorian-Shamagian, I. López-Rodríguez, 2009, International journal of cardiology.